
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (2) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Remove Biologicals filter Biologicals (2)
- Remove Blood and blood components filter Blood and blood components (0)
- Complementary medicines (7) Apply Complementary medicines filter
- Fees/Payments (1) Apply Fees/Payments filter
- Remove Import/Export filter Import/Export (1)
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Remove Legislation filter Legislation (3)
- Listed medicines (2) Apply Listed medicines filter
- Medical devices/IVDs (55) Apply Medical devices/IVDs filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- OTC medicines (12) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Prescription medicines (5) Apply Prescription medicines filter
- Remove Safety of medicines & medical devices filter Safety of medicines & medical devices (0)
- Scheduling (55) Apply Scheduling filter
- Remove Therapeutic Goods Administration (TGA) filter Therapeutic Goods Administration (TGA) (2)
- Therapeutic goods regulation (2) Apply Therapeutic goods regulation filter
- (-) Remove Therapeutic Goods Administration (TGA) filter Therapeutic Goods Administration (TGA)
- (-) Remove Import/Export filter Import/Export
- (-) Remove Blood and blood components filter Blood and blood components
- (-) Remove Biologicals filter Biologicals
- (-) Remove Safety of medicines & medical devices filter Safety of medicines & medical devices
- (-) Remove Legislation filter Legislation
Priority Review pathway for biologicals: feasibility, potential eligibility criteria and determination process
Closed on 28 March 2022
Consultation on potential regulatory options for 'export only' biologicals
Closed on 20 December 2021
Remaking of standards and legislative instruments for human cell and tissue (HCT) products, blood and blood components
Closed on 11 July 2021
Proposed improvements to the Therapeutic Goods Advertising Code
Closed on 18 June 2021
Standard for vaporiser nicotine (TGO 110)
Closed on 31 March 2021
Fees and charges proposal 2021-22
Closed on 17 March 2021
Export of therapeutic goods from Australia
Closed on 3 February 2020
TGA communications and consultation processes: Online survey 2009
Closed on 21 June 2009